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ABSTRACT
A prototype of a novel class of DNA alkylating
agents, which combines the DNA crosslinking
moiety chlorambucil (Chl) with a sequence-selective
hairpin pyrrole±imidazole polyamide ImPy-b-ImPy-g-
ImPy-b-Dp (polyamide 1), was evaluated for its
ability to damage DNA and induce biological
responses. Polyamide 1-Chl conjugate (1-Chl) alky-
lates and interstrand crosslinks DNA in cell-free
systems. The alkylation occurs predominantly at 5¢-
AGCTGCA-3¢ sequence, which represents the poly-
amide binding site. Conjugate-induced lesions were
®rst detected on DNA treated for 1 h with 0.1 mM
1-Chl, indicating that the conjugate is at least
100-fold more potent than Chl. Prolonged incuba-
tion allowed for DNA damage detection even at
0.01 mM concentration. Treatment with 1-Chl
decreased DNA template activity in simian virus 40
(SV40) in vitro replication assays. 1-Chl inhibited
mammalian cell growth, genomic DNA replication
and cell cycle progression, and arrested cells in the
G2/M phase. Moreover, cellular effects were
observed at 1-Chl concentrations similar to those
needed for DNA damage in cell-free systems.
Neither of the parent compounds, unconjugated Chl
or polyamide 1, demonstrated any cellular activity
in the same concentration range. The conjugate
molecule 1-Chl possesses the sequence-selectivity
of a polyamide and the enhanced DNA reactivity of
Chl.
INTRODUCTION
DNA alkylating agents, and in particular the nitrogen
mustards, remain an important class of antitumor drugs. For
example, the aromatic nitrogen mustard chlorambucil (Chl) is
routinely used in the chemotherapy of leukemias and
lymphomas, and in other tumors (1). The biological activity
of Chl and other nitrogen mustards is mediated through
alkylation of guanine N7 position in the DNA major groove,
and subsequent DNA interstrand crosslinking. The reaction is
determined largely by the molecular electrostatic potential of
the DNA, with alkylation occurring preferentially in the
middle of runs of guanines (2). These covalent modi®cations
of DNA, and especially interstrand crosslinks, lead to cell
death if not repaired. Because of their relatively simple
structure and high reactivity, nitrogen mustards have a very
limited DNA sequence selectivity and rapidly lose their
activity by non-speci®c interaction with a number of
nucleophilic groups on cellular biomolecules other than
DNA. Nitrogen mustards have been shown to be potentially
carcinogenic, mutagenic and teratogenic, and to promote
secondary malignancies (3,4), probably due to the non-speci®c
interactions.
Attempts to improve the selectivity of nitrogen mustards,
and to better target them to cancer cells in particular, have led
to development of several new strategies. One is to create
hybrid molecules that combine DNA targeting and DNA
damaging moieties. One of the most successful applications of
this scheme was the design of tallimustine (FCE 24517), a
hybrid molecule consisting of the benzoyl nitrogen mustard
and the AT-speci®c DNA minor groove binder distamycin.
Tallimustine possesses enhanced sequence-selectivity, alky-
lates adenine in the DNA minor groove, and is cytotoxic to
cancer cells (5). In order to further increase the sequence
selectivity of DNA damage, we have used synthetic
polyamides as DNA-targeting carriers [for recent review on
polyamides development see (6)]. The hairpin polyamides are
able to distinguish all four base pair combinations (GC, CG,
AT and TA) in the minor groove of DNA (7). Polyamides can
be designed to read DNA sequences up to 16 base pairs in
length (8,9).
To combine DNA targeting and damaging activities,
polyamide 1 which binds to the sequence 5¢-(A/T)GC(A/
T)GC(A/T)-3¢ with high af®nity (Ka~1010 M±1), was conju-
gated with the DNA alkylating/crosslinking agent Chl (10).
The resulting polyamide 1-Chl conjugate was shown to
alkylate single sites within a 241-bp DNA fragment (under the
cell-free conditions) (10). We test here whether such an
activity would be maintained on complex DNA molecules
and, importantly, whether 1-Chl possesses intracellular activ-
ity, in particular in comparison to that of the parent Chl, which
is an anticancer clinical drug.
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We compared the mode of DNA interaction and biological
activities of 1-Chl with the parent compounds, polyamide 1
(DNA recognizing/targeting moiety) and Chl (DNA alkylating
moiety). 1-Chl and its parent compounds were tested for their
ability to induce DNA damage, interfere with DNA replication
under cell-free and cellular conditions, and inhibit cell growth
and cell cycle progression. We ®nd that 1-Chl alkylates and
crosslinks DNA in vitro with high ef®ciency, and that
alkylation occurs predominantly at the sequence targeted by
the polyamide. Treatment of 293 cells with 1-Chl resulted in
G2/M phase arrest and DNA synthesis and growth inhibition.
Conjugate 1-Chl exhibited higher activity (at least 100-fold)
than its separate components, polyamide 1 and Chl, in every
cell-free or cellular system tested, and demonstrated cytotoxic
effects in several mammalian cell lines.
MATERIALS AND METHODS
Chemicals
1-Chl (ImPy-b-ImPy-(R) CHL-g-ImPy-b-Dp), polyamide 1
(10) and Chl (Sigma, Saint Louis, MO) stock solutions were
prepared in distilled water, and diluted in reaction buffer or
cell culture medium before use. Simian virus 40 (SV40) DNA
was purchased from Gibco/Life Technologies (Grand Island,
NY), as were all cell culture materials. [a-32P]dCTP
(3000 Ci/mmol), [a-32P]dATP (3000 Ci/mmol) and [g-32P]ATP
(5000 Ci/mmol) were from Amersham (Piscataway, NJ).
In vitro ligand±DNA reaction
All conjugate±DNA reactions were carried out at 37°C with
0.01 mg/ml SV40 DNA (linear, supercoiled or minichromoso-
mal) in 25 mM triethanolamine, 1 mM EDTA, pH 7.2 (total
vol 30 ml), for the time indicated, and terminated by addition
of stop solution (®nal concentrations 1% SDS, 0.3 M sodium
acetate, 5 mM EDTA). Samples were subsequently extracted
with phenol/chloroform/isoamyl alcohol (PCI) mixture
(25:24:1), precipitated with 3 vol 95% ethanol, washed with
70% ethanol, and dissolved in 10 mM Tris±HCl, 1 mM EDTA,
pH 7.5 (TE) buffer.
SV40 DNA cross-linking in vitro
A cross-link assay was carried out according to Hartley et al.
(11) with some modi®cations. SV40 DNA, linearized (BamHI,
Boeheringer Mannheim, Indianapolis, IN) and dephosphory-
lated (calf intestinal phosphatase, Sigma), was 32P-5¢-end-
labeled using T4 polynucleotide kinase (Boehringer
Mannheim). Following puri®cation on G50 Quick Spin
columns (Boehringer Mannheim) and precipitation, the
DNA was resuspended in TE buffer at 1 mg/ml, and speci®c
activity was quantitated by liquid scintillation. Labeled DNA
(~10 000 c.p.m.) was mixed with 0.3 mg of `cold' SV40 DNA,
incubated with the studied compounds and puri®ed as
described above. Dried samples were dissolved in strand
separation buffer (65% formamide, 1 mM EDTA, 0.04% of
each bromophenol blue/xylene cyanol), heated at 55°C for
10 min and chilled immediately on ice. DNA was resolved on
1% agarose gels in 13 Tris±acetate electrophoresis (TAE)
buffer at 1 V/cm for 16 h. The DNA bands were visualized and
quantitated with a PhosphorImager Scanner and ImageQuant
v.5 software (Molecular Dynamics, Sunnyvale, CA).
SV40 DNA forms conversion
Ligand-induced DNA damage was measured using a forms
conversion assay (12). Supercoiled SV40 DNA (0.3 mg) was
treated with the studied compounds and then puri®ed as
described above. In some experiments, SV40 DNA mini-
chromosomes were used according to a previously described
method (13). Ligand-treated and precipitated DNA was
resuspended in TE, heated at 70°C for 2 h to convert
alkylation sites into strand breaks, and resolved on 1% agarose
gels in 13 TAE at 1 V/cm for 16 h. Separated SV40 DNA
forms were visualized and quantitated with the ChemiImager
4400 System (AlphaInnotech, San Leandro, CA).
Repetitive primer extension (RPE)
SV40 DNA treated with the studied agents or untreated
controls were used in RPE experiments (14). The primer (5¢-
CCCAAGGCTCATTTCAGGC-3¢, starting from position
2818/reverse on the SV40 genome, synthesized by the
Biopolymer Facility at Roswell Park Cancer Institute), was
32P-5¢-end-labeled with T4 polynucleotide kinase (Boehringer
Mannheim), puri®ed and used directly in thermal cycling. A
linear ampli®cation reaction (25 ml) consisted of 100 ng of
SV40 DNA (control or drug-treated), labeled primer (0.5 mM),
1 U Taq DNA polymerase, 1.5 mM MgCl2 and 0.2 mM of
each dNTP, in 13 Taq polymerase buffer (Life Technologies).
The polymerase reaction was started with 5 min denaturation
at 95°C and carried out for 35 cycles of 30 s at 95°C, 30 s at
55°C and 55 s at 72°C. The standard sequencing reactions
were performed according to the manufacturer's instructions
using SequiTherm Excel II kit (Epicentre Technologies,
Madison, WI) and the same primer. DNA fragments were
separated on 8% polyacrylamide/8.3 M urea sequencing gels
in 13 Tris±borate electrophoresis (TBE) buffer. Gels were
dried and DNA replication products were visualized by
phosphorimaging.
Cell-free SV40 DNA replication
The method and conditions used for SV40 cell-free DNA
replication were as described previously (15). The total
cellular protein extracts were prepared from non-treated,
exponentially growing 293 cells by hypotonic buffer extrac-
tion, and protein concentrations were determined using the
Bradford method (Bio-Rad Laboratories, Hercules, CA).
Ligand-modi®ed template DNA was prepared by incubating
SV40 DNA (150 ng, form I) with 1-Chl at 37°C for 1 h,
followed by phenol-chloroform extraction and precipitation as
described above. 1-Chl-treated template DNA (50 ng) was
mixed with 293 cell extracts (50 mg proteins), 600 ng of
T antigen, and 2 mCi of [a-32P]dATP in the replication buffer.
The reactions (®nal vol 20 ml) were incubated at 37°C for 1 h,
and then stopped by addition of 1% SDS, 10 mM EDTA and
0.1 mg/ml proteinase K. Following 30 min incubation at 37°C
and PCI extraction, DNA was puri®ed on G50 Quick Spin
column and separated on 0.8% agarose gels in 13 TAE for
16 h at 1 V/cm. The DNA replication products were visualized
and quantitated by phosphorimaging.
Cell culture and cell growth inhibition
HeLa S3, HCT-116, 293 and BSC-1 cells were grown
as a monolayer, and Jurkat cells as suspension culture, in
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appropriate media at 37°C in a 5% CO2 incubator.
Exponentially growing cells were plated in 96-well plates at
a density of 1 3 103 cells/well. After overnight incubation,
the cells were treated with the studied compounds for
4 days, followed by washing and ®xing with 50% cold
trichloroacetic acid. Cell growth was quantitated based
upon Sulphorhodamine B staining of cellular proteins and
absorbance measurements at 570 nm.
Inhibition of DNA, RNA and protein synthesis
Inhibition of cellular macromolecule synthesis was measured
as [3H]-precursors incorporation into cells as described
previously (15). Brie¯y, 293 cells were pre-labeled with
[14C]thymidine (0.01 mCi/ml) for 48 h, followed by a 24 h
chase in fresh medium. Cells plated in 6-well plates (1 3 105
cells/well) were treated with 1-Chl for 18 h, and during the last
1 h [3H]thymidine, uridine or leucine were added to a ®nal
concentration 0.5 mCi/ml. Following washes in phosphate-
buffered saline, pH 7.4, and macromolecules precipitation
with cold perchloric acid, the acid-insoluble radioactivity in
samples was quantitated using liquid scintillation. Inhibition
of precursors incorporation into cellular macromolecules was
calculated as the ratio of [3H] to [14C] in drug-treated sample
compared with non-treated control.
DNA content determination by ¯ow cytometry
Exponentially growing 293 cells were treated with 1-Chl or
Chl for 18 h followed by an additional 24 h incubation in drug-
free medium. Harvested cells were ®xed in 75% ethanol at
±20°C for at least 18 h. Cellular DNA was stained for 30 min
in the dark at room temperature in 0.1% sodium citrate
containing 50 mg/ml propidium iodide (PI) (Sigma) and
100 mg/ml RNase A (Boehringer Mannheim). The DNA
content in 104 cells/sample was measured by ¯ow cytometry
on a FACSscan apparatus (Becton-Dickinson, Franklin Lakes,
NJ), and analyzed with WinList 5.0 program (Verity Software
House, Topsham, ME).
RESULTS
Conjugate-induced effects on SV40 DNA in cell-free
systems
Induction of DNA interstrand crosslinks. The Chl moiety
attached to a polyamide in 1-Chl should cause DNA alkylation
and crosslinking (Fig. 1). Alkylation of complementary DNA
strands by one Chl molecule could result in interstrand
crosslinking that prevents the separation of DNA strands. The
formation of crosslinks in DNA can therefore be measured by
denaturation of conjugate-treated linear DNA, followed by
separation on neutral agarose gels (11). However, methods
often employed in the detection of DNA interstrand crosslinks
involve the use of harsh procedures (high temperature or pH)
to denature the DNA duplex. Since the stability of DNA
alkylation/crosslinks could be compromised under such con-
ditions, we employed a mild method that involved heating the
linear DNA in 65% formamide at 55°C for 10 min. Under
these conditions, control DNA can be fully denatured (Fig. 2A
and B, lanes 2) while at the same time alkali- or heat-labile
crosslinks are preserved.
Treatment with increasing concentration of 1-Chl increased
the fraction of double-stranded DNA that was resistant to
denaturation (Fig. 2A, lanes 5±7). Crosslinks could be
detected at agent concentrations as low as 0.1 mM, and at
1 mM 1-Chl ~50% of the plasmid was crosslinked and
migrated as double-stranded DNA (Fig. 2A, chart). Under
similar conditions, none of the parent agents (Fig. 2A, Chl,
lane 3 or polyamide 1, lane 4) induced DNA interstrand
crosslinks. The time dependence of 1-Chl-induced DNA
crosslinking was investigated by incubating SV40 DNA with
10 mM conjugate for up to 24 h at 37°C. As shown in
Figure 2B, the level of DNA crosslinks increased rapidly and
reached the value of 75% of total DNA after 60 min treatment
(Fig. 2B, chart). Longer exposures to 1-Chl resulted in DNA
degradation, which manifested as a low molecular `smear' on
the gels (data not shown).
Sequence selectivity of DNA damage in cell-free systems. 1-
Chl and its parent polyamide 1 were designed to target the
speci®c DNA sequences, 5¢-(A/T)GC(A/T)GC(A/T)-3¢.
Previous study con®rmed the sequence preference of 1-Chl
using a small DNA fragment. In this work, we further tested
the agent's sequence selectivity on a relatively large (5243 bp)
circular SV40 DNA using the RPE assay (also known as the
`polymerase stop assay') (14). Here, the conjugate-induced
lesions (covalent adducts, crosslinks, strand breaks, etc.) on
template DNA prematurely stop Taq polymerase-catalyzed
primer extension, resulting in partially extended products
whose length indicate the positions of the DNA damage with a
1±2 bp resolution.
First, the heat-induced conversion of agent±DNA adducts to
DNA strand breaks was used to establish the proper conditions
for 1-Chl±DNA interactions. In this assay, a single strand
break results in the conversion of DNA form I (supercoiled) to
form II (open circular), while the formation of DNA form III
(linear) requires a frank double strand break or two closely
spaced single strand breaks on opposite strands (12). To
enhance the sequence selectivity of DNA alkylation by 1-Chl,
relatively low agent concentrations and long incubation times
(up to 24 h) were tested (10).
Figure 1. Structure of 1-Chl and model of its binding site. (A) Chemical
structure of polyamide±Chl conjugate 1-Chl. (B) Model of polyamide
conjugate bound to the match site 5¢-AGCTGCT-3¢. Shaded and non-shaded
circles represent imidazole and pyrrole rings, respectively, diamonds
represent b-alanine and hexagon represents Chl.
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Forms conversion assay was carried out using naked SV40
DNA incubated with 1-Chl (0.001±1 mM) for 18 h at 37°C
(Fig. 3A). After heating at 70°C, increase in linear (form III)
and nicked-circular (form II) DNA could be detected at 0.01
mM 1-Chl (Fig. 3A, lane 3), and a signi®cantly higher level of
DNA damage was observed at 1 mM conjugate (Fig. 3A, lane
5). In contrast, the parent compounds, polyamide 1 and Chl,
did not induce measurable DNA damage at concentrations up
to 10 mM (data not shown). DNA template prepared by
reaction of 1 mM 1-Chl with SV40 DNA for 18 h was used in
subsequent RPE experiments.
Ampli®cation of non-treated SV40 DNA (lane 5) in RPE
experiment resulted in long extension products that migrated
near the top of the gel (beyond the region shown in Fig. 3B).
The parent compounds including Chl and polyamide 1 that
were inactive in previous assays showed virtually no inhib-
ition of primer extension at concentrations as high as 10 mM
(data not shown). In contrast, SV40 DNA treated with 1 mM
1-Chl for 18 h at 37°C and subjected to the RPE reaction
produced several distinct bands corresponding to shorter DNA
fragments (Fig. 3B, lane 6). The intense bands at
A¬AGCTGCAA¬ sequence (the arrows indicate presumed
alkylated bases) demonstrate that under these conditions,
1-Chl targets its designed sequence. However, besides the
polyamide match site, 1-Chl also damaged one of the
downstream mismatch sites (Fig. 3B, lane 6, lower part,
A¬A¬GCAAGT; the arrows indicate presumed alkylated
bases and the mismatched bases are underlined).
Inhibition of cell-free SV40 DNA replication. A cell-free SV40
DNA replication assay was employed to examine the func-
tional effects of 1-Chl-induced DNA damage. In this assay, the
template SV40 DNA was combined with replication factors
isolated from exponentially growing 293 cells and supple-
mented by SV40 large T antigen. Under these conditions, it is
possible to fully replicate the SV40 genome in a cell-free
environment (16).
1-Chl-treated SV40 DNA (0.3 and 3 mM 1-Chl for 1 h at
37°C) was used as the template in the replication reaction
carried out as described in Materials and Methods. As shown
in Figure 4, treatment of SV40 DNA with as low as 0.3 mM
1-Chl decreased the template competency for replication
reaction by ~25% (lane 2), whereas DNA treated with 3 mM
1-Chl was virtually inactive in the replication reaction (lane 3).
Figure 3. Sequence selectivity of 1-Chl-induced DNA alkylation. (A) SV40
DNA alkylation induced by 1-Chl (0.001±1 mM) following prolonged
incubation (18 h at 37°C). DNA alkylation lesions were converted to strand
breaks as described in Materials and Methods. (B) Sequence selectivity of
1-Chl-induced SV40 DNA alkylation. Template DNA (0.3 mg) was either
reacted with 1 mM 1-Chl for 18 h at 37°C (lane 6) or untreated (control,
lane 5). Following extraction and ethanol precipitation, DNA samples
(0.1 mg) were subjected to the RPE reaction using 32P-end-labeled primers
(starting from position 2818/reverse on the SV40 genome) and resolved on
sequencing polyacrylamide gels as described in Materials and Methods.
DNA fragments were visualized by phosphoimaging analysis. Arrows
indicate 1-Chl binding sites, and GATC (lanes 1±4) represent results of
sequencing reactions using the same DNA primers.
Figure 2. Formation of DNA interstrand cross-links on SV40 DNA by
1-Chl, polyamide 1 and Chl. (A) Dose dependence. SV40 DNA was
incubated at 37°C for 1 h with 10 mM of Chl (lane 3) polyamide 1 (lane 4)
or 0.1±10 mM 1-Chl (lanes 5±7). (B) Time dependence. SV40 DNA was
incubated at 37°C with 10 mM 1-Chl for 0, 5, 15 and 60 min (lanes 3±6).
Lanes 1 and 2 represent native, double-stranded (ds) and denatured,
single-stranded (ss) control SV40 DNA, respectively. Linearized and [32P]
end-labeled SV40 DNA was treated with agents, puri®ed, denatured and
resolved on neutral agarose gels as described in Materials and Methods. The
percentage of double-stranded and resistant to denaturation cross-linked
DNA was determined by phosphoimaging analysis of dried gels. The data
points in the charts represent the average of at least two independent
experiments.
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The IC50 (50% inhibitory concentration) calculated from the
graph was 0.9 mM. Since the free agent was presumably
completely removed from DNA by extraction and precipita-
tion, the loss of replication activity can be attributed to 1-Chl-
induced irreversible damage to DNA template.
Cellular effects
DNA, RNA and protein synthesis inhibition. The results
presented so far demonstrated that 1-Chl alkylates and
crosslinks DNA with the desired sequence selectivity, and
inhibits DNA replication in cell-free systems in vitro.
However, the question remains how this in vitro activity,
detected on naked SV40 DNA, translates into cellular effects.
Since 1-Chl inhibited DNA replication in cell-free system, we
have started evaluation of the agent cellular activities by
testing the macromolecules synthesis in human 293 cells after
18 h treatment with 1-Chl.
The conjugate-treated cells were examined for bulk DNA,
RNA and protein synthesis by measurement of [3H]-
thymidine, [3H]uridine and [3H]leucine incorporation, respect-
ively. As shown in Figure 5, agent dose-dependent decrease in
thymidine incorporation into genomic DNA was observed
after 18 h incubation with 0±10 mM of 1-Chl. The highest
studied concentration (10 mM) was suf®cient to inhibit DNA
synthesis by ~85% (shaded circles), however, there was
virtually no inhibition of RNA (shaded squares) or protein
synthesis (open squares). Under similar conditions, neither
polyamide 1 nor Chl was able to inhibit DNA, RNA or protein
synthesis (data not shown).
Cell growth inhibition. Exponentially growing 293 cells were
treated for 4 days at 37°C with 1-Chl concentrations ranging
from 0.001 to 10 mM. The IC50 was observed at ~0.013 mM
1-Chl (Fig. 6A, shaded circles). No signi®cant growth
inhibition was detected in 293 cells treated with similar
concentrations of Chl (open squares) or polyamide 1 (shaded
squares). This observation corroborates with and extends our
previous results showing the highly enhanced activity of 1-Chl
compared with its parent compounds.
Additional studies conducted with several cell lines
produced interesting observations that 1-Chl growth inhibition
activities are cell line-dependent (Table 1). The concentration
which inhibited cell growth by 50% varied from 2 nM (Jurkat
cell line) to >2 mM (BSC-1 and HCT-116 cell lines). In
addition to evaluating growth inhibition of 1-Chl in tumor
lines, normal human diploid ®broblast cells (IMR 90) were
also found to be insensitive up to concentrations as high as
2 mM (personal communication from Athena Lin and Tonya
Jackson). In addition, IMR 90 cells neoplastically transformed
with ras, which greatly enhances their susceptibility to
DNA-damaging drugs, were found to be only slightly sensitive
to 1-Chl (~50% growth inhibition required 2 mM treatment).
Unlike 1-Chl, Chl showed similarly low activity against 1-Chl
sensitive (293) or insensitive (BSC-1) cells. The extraordinary
differences in sensitivity of cells to 1-Chl cannot be explained
by differences in media composition or culture conditions
(data not shown).
Cell cycle perturbations. DNA interacting/damaging agents
are known to induce cell cycle perturbations and arrest the cell
cycle progression predominantly at the G2/M boundary (17).
The monoparametric ¯ow cytometry method was used to
evaluate 1-Chl effects on cell cycle progression. Expo-
nentially and asynchronously growing 293 cells were treated
with 0.01±1 mM 1-Chl or Chl for 18 h, followed by 24 h
incubation in agent-free medium. After the cellular DNA was
stained with PI, DNA content was analyzed by ¯ow cytometry
as described in Materials and Methods.
The histograms of the DNA content distribution in cells
treated with 1-Chl or Chl are shown in Figure 6B. In control,
non-treated samples, the majority of cells are in the G1 phase.
However, treatment with increased doses of 1-Chl resulted in a
gradual increase in the proportion of the G2/M peak (up to
53% at 1 mM 1-Chl), thus indicating that 1-Chl is able to
arrest cell cycle progression in G2/M phase. Under similar
Figure 4. 1-Chl-treated DNA is a poor template for replication in cell-free
system. Naked SV40 DNA was treated with 1-Chl at the indicated
concentrations for 1 h at 37°C. Replication reactions were assembled using
30 mg of 293 cells extract, 50 ng of drug-treated SV40 DNA and 0.6 mg of
SV40 T-antigen, and incubated at 37°C for 1 h. Replication products were
puri®ed, resolved on 0.8% neutral agarose gels (A), and quantitated (B) as
described in Materials and Methods. Positions of plasmid topoisomers (TI)
and replication intermediates (RI) are indicated. The data points in the chart
represent the average of two independent experiments.
Figure 5. Inhibition of DNA, RNA and protein synthesis in 293 cells.
Exponentially growing 293 cells were treated for 18 h with 1-Chl
(0.01±10 mM), followed by 1 h incubation with [3H]thymidine (DNA,
shaded circles), [3H]uridine (RNA, shaded squares) and [3H]leucine
(proteins, open squares). The percentages of inhibition of the precursors
incorporation into DNA, RNA and proteins were determined as described in
Materials and Methods. The data points represent the average of two
independent experiments.
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conditions, Chl did not alter cell cycle distribution (Fig. 6B,
right panel). In a similar study using BSC-1 cells, 1-Chl
concentrations as high as 20 mM and incubation times up to
48 h, resulted in no effect on cell cycle progression essentially
mirroring the resistance seen for growth inhibition (data not
shown).
DISCUSSION
It was shown previously, that 1-Chl alkylates N3 adenines in
a polyamide-targeted, sequence-selective manner (10). How-
ever, it was not known if the drug-induced DNA alkylation/
damage lesions were single-stranded (DNA monoadducts) or
double-stranded (DNA interstrand crosslinks). Therefore, we
tested whether the ability of Chl to crosslink DNA was altered
because of coupling with a polyamide. The lack of strand
separation of full length linear SV40 treated with 1-Chl under
denaturing conditions proved the formation and covalent
nature of 1-Chl-induced crosslinks. The parent polyamide 1,
which lacks Chl moiety, was unable to crosslink double-
stranded DNA under these conditions, thus excluding the
possibility that the strong, but non-covalent binding of
polyamide to DNA contributes to crosslinking appearance.
Furthermore, 1-Chl was a much more ef®cient DNA cross-
linking agent than its parent nitrogen mustard Chl, which
under the same conditions did not induce crosslinks at
concentrations up to 10 mM, although some crosslinks were
observed at higher concentrations (data not shown). It has
been noted previously that Chl±distamycin conjugates cross-
link naked and cellular DNA more ef®ciently than Chl alone
(18), probably due to the more ef®cient and faster delivery of
Chl alkylating groups to the DNA reactive sites.
The DNA crosslinking assay demonstrated the improved
DNA damaging activity of 1-Chl, compared to Chl. Since this
assay is based on ligand interactions with simple linear DNA
molecules, 1-Chl alkylation potency was also studied using
more complex, supercoiled SV40 DNA. Neither Chl nor
polyamide 1 produced DNA damage at concentrations up to
10 mM, while DNA damage (demonstrated as conversion of
supercoiled form I DNA to forms II and III) was observed at
1-Chl concentrations ranging from 0.1 to 10 mM (1 h treatment
at 37°C). Longer treatments with 1-Chl further increased the
level of drug-induced DNA damage, and the ®rst DNA strand
breaks could be detected at concentrations as low as 0.01 mM
following 18 h exposure (Fig. 3A). However, prolonged
incubation and higher 1-Chl concentrations led to extensive
DNA damage, resulting in smaller fragments.
The DNA forms conversion assay was also employed to
study drug interactions with SV40 minichromosomal DNA,
e.g. DNA protected by nucleosomal histones and other
chromatin proteins. Studies using SV40 minichromosomal
DNA demonstrated that the presence of chromatin structure
has no effect on the amount of DNA damage produced by
1-Chl (data not shown). Overall, 1-Chl DNA damaging
activity as tested in crosslinking and forms conversion assays
were similarly independent of DNA structure (linear, circular
or minichromosomal) and occurred at concentrations signi®-
cantly lower than concentrations needed for Chl to damage
DNA.
As shown with RPE experiments, 1-Chl appears to target
Chl to its polyamide DNA binding sequence. Taq polymerase
was arrested at the sequences matching the polyamide 1 DNA-
binding sequence 5¢-(A/T)GC(A/T)GC(A/T)-3¢ (Fig. 3B,
upper part, AGCTGCA), as well as double-base pair mismatch
site (Fig. 3B, lower part, AGCAAGT). It has been demon-
strated previously that the speci®city for the alkylation at
Figure 6. Inhibition of cell growth and cell cycle progression induced by
1-Chl and its parent compounds in 293 cells. (A) Growth inhibition of 293
cells treated for 96 h with 0.001±5 mM of 1-Chl (shaded circles), Chl (open
squares) or polyamide 1 (shaded squares). The percentage inhibition of cell
growth was determined using standard sulphorhodamine method as
described in Materials and Methods. The data points represent the average
of at least two independent experiments done in triplicate. (B) Drug-induced
cell cycle perturbation in 293 cells. Cellular DNA content in cells treated
for 18 h with 0.01, 0.1 and 1 mM of 1-Chl (left panel) or Chl (right panel),
and then post-incubated in fresh medium for 24 h was evaluated by ¯ow
cytometry as described in Materials and Methods.
Table 1. 1-Chl-induced cell growth inhibition
Cell line Cell line description IC50 [nM]
a
Jurkat Human T cell leukemia 2.2
293 Human transformed embryonic kidney 13
HeLa S3 Human epithelial carcinoma 200
BSC-1 African green monkey kidney >2000
HCT-116 Human colon carcinoma >2000
aCells were drug treated for 4 days, then the growth was quantitated based
upon sulphorhodamine B staining of cellular proteins and absorbance
measurements at 570 nm as described in Materials and Methods.
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match sites over mismatch sites is ~20-fold (10). However, on
the particular SV40 DNA fragment analyzed in this study both
match and double-base pair mismatch sites appear to be
alkylated. One could imagine lower occupancy at a mismatch
site, but faster rate of alkylation affording similar yield of
cleavage at two different sites.
Besides demonstrating the sequence selectivity of 1-Chl-
induced DNA damage, the RPE experiments also revealed that
the conjugate-induced lesions stop DNA polymerase in the
PCR reaction, and could potentially inhibit DNA synthesis.
Therefore, the cell-free in vitro SV40 DNA replication assay
was used to study the effects of 1-Chl-induced DNA alkylation
on DNA synthesis. The 1-Chl-treated DNA was unable to
serve as a DNA synthesis template, with nearly complete
replication inhibition observed at 3 mM 1-Chl. This inhibitory
activity could be attributed to formation of DNA crosslinks
between the complementary strands, which was observed in
the range 1±10 mM (Fig. 2A), and the IC50 values calculated
from both experiments are very close (0.9 and 1 mM). DNA
interstrand crosslinks have been postulated to inhibit or
prevent replication, as well as transcription of cellular DNA,
because these processes require that the complementary DNA
strands be free to separate and bind proteins, a process that is
perturbed by the presence of covalent links.
A number of studies have shown a direct correlation
between the degree of DNA interstrand crosslinking and
biological responses to alkylating agents both in vitro and
in vivo (19±21). Therefore, one can presume that 1-Chl, as an
active and ef®cient DNA alkylating and crosslinking agent,
would induce biological effects in mammalian cells. Short-
term (4 days continuous incubation) assays showed that 1-Chl
inhibits the growth of the 293 human cell line at doses similar
to those active in cell-free DNA damaging experiments (IC50
= 0.013 mM). It is important to emphasize that Chl induces
DNA interstrand crosslinks and inhibits cell growth at
concentrations ranging from micromolar to millimolar
depending on the cell line, therefore attachment of se-
quence-selective polyamide moiety can improve Chl activity
by several orders of magnitude.
Factors that may enhance 1-Chl cytotoxicity as compared to
Chl include the sequence selectivity of crosslinking and the
degree of DNA structure distortion by the formation of larger
adducts. Both factors may affect the cell's ability to recognize
and repair DNA lesions. It has been shown for a series of
nitrogen mustards±minor groove binders conjugates that,
while the overall crosslinking ef®ciency did not dramatically
change with the increase in the agents' length, the sequence
selectivity of alkylation and the cytotoxicity were consider-
ably enhanced (22,23).
Relatively low 1-Chl concentrations (1 mM for 18 h) were
able to induce DNA synthesis inhibition (Fig. 5) and a G2/M
block in the cell cycle (Fig. 6B). Under the same conditions,
the parent compounds, polyamide 1 and Chl, did not inhibit
cell growth or cell cycle progression. DNA crosslinking
agents, as well as other types of DNA damaging drugs, are
known to inhibit cellular DNA replication and arrest cells in
G2/M (17,24). Thus, the preferential inhibition of DNA
replication and G2/M block suggest that 1-Chl damages
intracellular, genomic DNA in a fashion similar to that
observed for cell-free SV40 DNA.
This study demonstrates the cellular activity of a
polyamide±Chl conjugate. Interestingly, our recent uptake
and nuclear localization study of polyamide-dye conjugates
using confocal laser scanning microscopy revealed that
polyamides localize mainly in the cytoplasm, not the nucleus
of most cell types (25). The fact that signi®cant biological
activity is seen in selected cell types with the conjugate
polyamide, suggests that for 1-Chl, fewer DNA lesions may be
needed to impair DNA template function compared to
reversible binding polyamides. Similarly, a polyamide conju-
gated to a DNA alkylating group from the cyclopropylpyrro-
loindole family also showed signi®cant enhancement of whole
cell activity (26). The yet unexplained differences between the
growth inhibitory activities of 1-Chl on various cell lines
could be caused by the differences in cellular uptake or more
likely intracellular transport of this agent as suggested by
uptake studies in which polyamide-dye conjugates were
restricted to certain T-cell lines (25).
In summary, studies presented here have demonstrated that
the Chl-conjugated polyamide 1-Chl binds and alkylates DNA
in vitro. The compound-induced DNA damage occurs pre-
dominantly at the designated polyamide-binding site and
hinders DNA template functionality with regard to replication
in vitro. Compared with its parent compounds, polyamide 1
and nitrogen mustard Chl, the conjugate molecule is far more
effective in both in vitro cell-free and cellular tests. 1-Chl
damages and crosslinks SV40 DNA at concentrations as low
as 0.01 and 1 mM, respectively, whereas polyamide 1 and Chl
did not demonstrate any activity up to 10 mM. In addition,
1-Chl arrests cells in the G2/M phase and inhibits cell growth
and DNA replication, while neither of the parent compounds
showed activity at concentrations up to 10 mM.
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